摘要
目的研究毒胡萝卜素(thapsigargin)联合吉非替尼(gefitinib)对人肺腺癌耐药细胞株PC9/GR增殖的影响并探讨可能的机制。方法吉非替尼单独用药或吉非替尼与毒胡萝卜素联合应用,通过CCK8实验检测上述两组药物对PC9/GR细胞增殖的影响;应用流式细胞术鉴定两组药物对PC9/GR细胞凋亡的影响;应用Western blotting法检测两组药物对PC9/GR细胞蛋白ATF-6和IRE1α表达的影响。结果细胞增殖实验显示,与吉非替尼单独用药相比,联合用药组中PC9/GR的增殖受到更强的抑制作用;凋亡实验显示,相较于吉非替尼单独用药,联合用药能够进一步促进细胞的凋亡;Western blotting法显示,与吉非替尼单独用药相比,联合用药后PC9/GR中ATF-6和IRE1α蛋白(内质网应激标志物)表达上调,其差异具有统计学意义。结论在毒胡萝卜素诱导下,PC9/GR细胞对吉非替尼的敏感性增加,其中机制可能与内质网应激有关。
Objective To study the effect and mechanism of the thapsigargin combined with gefitinib on the proliferation of human lung adenocarcinoma gefitinib resistance cell line PC9/GR.Methods The cell viability of PC9/GR treated with gefitinib alone or gefitinib combined with thapsigargin was evaluated by CCK8 assay.The flow cytometry was used to analyze the PC9/GR cell apoptosis indued by the two group drugs.The ATF-6 and IRE1αprotein expression of PC9/GR cells treated with the two group drugs were detected by Western blotting.Results The group of drug combination exhibited enhanced ability to inhibit cell proliferation,promote cell apoptosis and upregulate the ATF-6 and IRE1αprotein expression of the PC9/GR compared with the group gefitinib used alone.Conclusion The sensitivity of PC9/GR to gefitinib was increased when the cells were treated by thapsigargin,which may be related with the state of endoplasmic reticulum stress(ERS)induced by thapsigargin.
作者
杜江源
张兰林
蔡同凯
曹永兵
DU Jiangyuan;ZHANG Lanlin;CAI Tongkai;CAO Yongbing(Institute of Vascular Diseases,Shanghai TCM-Integrated Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200082,China;Shanghai Tongji Hospital,Shanghai 200065,China;Naval Medical University,Shanghai 200433,China)
出处
《药学实践与服务》
CAS
2024年第3期121-126,共6页
Journal of Pharmaceutical Practice and Service
基金
上海市虹口区卫健委面上项目(虹卫2002-02)。
关键词
吉非替尼
毒胡萝卜素
肿瘤耐药
凋亡
内质网应激
gefitinib
thapsigargin
tumor drug resisdance
apoptosis
endoplasmic reticulum stress